Who
James S. Turley
Director
Company insider
Files Form 4 as: Director, Citigroup; Director, Northrop Grumman; Director, Precigen; Director, Emerson Electric.
In numbers
- Trades disclosed
- 203
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 10 Jul 2013
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $8546.49 at $131.59 | filing |
| 1 Oct 2026filed 2 Oct 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $26K200.846 at $131.59 | filing |
| 1 Jul 2026filed 2 Jul 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $7625.343 at $142.56 | filing |
| 1 Jul 2026filed 2 Jul 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $24K165.335 at $142.56 | filing |
| 1 Jul 2026filed 2 Jul 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $7615.34 at $142.56 | filing |
| 1 Jul 2026filed 2 Jul 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $24K165.34 at $142.56 | filing |
| 20 May 2026filed 21 May 2026 | NOC Northrop GrummanAerospace & Defense | SEC FORM 4 Code A | $193K349 at $552.17 | filing |
| 20 May 2026filed 21 May 2026 | NOC Northrop GrummanAerospace & Defense | SEC FORM 4 Code A | $193K349 at $552.17 | filing |
| 1 Apr 2026filed 2 Apr 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $7586.826 at $110.99 | filing |
| 1 Apr 2026filed 2 Apr 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $23K211.215 at $110.99 | filing |
| 1 Apr 2026filed 2 Apr 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $7586.83 at $110.99 | filing |
| 1 Apr 2026filed 2 Apr 2026 | C CitigroupMoney-centre banks | SEC FORM 4 Code A | $23K211.22 at $110.99 | filing |
| 13 Mar 2026filed 16 Mar 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —71,839 | filing |
| 13 Mar 2026filed 16 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —71,839 at $0.00 | filing |
| 13 Mar 2026filed 16 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —71,839 at $0.00 | filing |
| 13 Mar 2026filed 16 Mar 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —71,839 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code A | $62K17,806 at $3.51 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,612 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,073 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,612 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.